Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y₁₂ antagonism

By Jakubowski Joseph A.   Zhou Chunmei   Egan Blaine   Wells Maggie   Kotob-Yahfoufi Maya   Sugidachi Atsuhiro   Dahlen Jeffrey R.  

Platelets, Vol. 22, Iss. 8, 2011-12 ,pp. : 619-625

Informa Healthcare

Access to resources Recommend Favorite

Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y₁₂ assay

By Kim In-Suk   Jeong Young-Hoon   Kang Min-Kyung   Koh Jin-Sin   Park Yongwhi   Hwang Seok-Jae   Kwak Choong   Hwang Jin-Yong   Kim Sunjoo  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 4, 2010-11 ,pp. : 486-495

Springer Publishing Company

Access to resources Recommend Favorite

Intra-individual variability of residual platelet reactivity assessed by the VerifyNow-P2Y12 assay in patients with clopidogrel resistance after percutaneous coronary intervention

By Ahn Sung Gyun   Lee Seung-Hwan   Sung Joong Kyung   Kim Jang-Young   Yoon Junghan  

Platelets, Vol. 22, Iss. 4, 2011-06 ,pp. : 305-307

Informa Healthcare

Access to resources Recommend Favorite

The P2Y₁₂ receptor as a therapeutic target in cardiovascular disease

By Storey R. F.  

Platelets, Vol. 12, Iss. 4, 2001-06 ,pp. : 197-209

Informa Healthcare

Access to resources Recommend Favorite

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis

By  

Neuroepidemiology, Vol. 46, Iss. 4, 2016-04 ,pp. : 292-300

Karger

Access to resources Recommend Favorite